CVS vs TSM Stock Comparison
Compare CVS and TSM across AIQ Score, fundamentals, valuation, momentum, risk, analyst expectations and current market evidence.
What is the main difference between CVS and TSM?
TSM leads the current stock comparison as Taiwan Semiconductor Manufacturing Company Limited, with the clearest separation coming from quality and the broader AIQ evidence mix.
AlgovestIQ AIQ Comparison
CVS Health Corp. vs Taiwan Semiconductor Manufacturing Company Limited
TSM leads
TSM leads by 19 AIQ points, primarily on Quality and Momentum.
Stable: 5 of 6 evidence groups support TSM, and its signal state is cleanly positive.
CVS Health Corp.
Taiwan Semiconductor Manufacturing Company Limited
The Algovestiq AIQ Score currently favors TSM over CVS, 70 versus 51 as of Sep 11, 2026. TSM's advantage is driven primarily by stronger quality and momentum, while CVS holds the stronger value profile. TSM also shows the stronger technical structure relative to its 50-day moving average. 5 of 6 covered evidence groups favor TSM today, and the comparison is rated Stable on stability. TSM lead: Stable — the AIQ differential has held near 19 points over 30 sessions.
Compare CVS Health Corp. and Taiwan Semiconductor Manufacturing Company Limited across the Algovestiq AIQ Score, valuation, quality, momentum, risk, technicals and analyst expectations.
Performance over time
Price-return comparison using available daily close history.
Total return comparison
Growth of $10,000
Based on available close-price history. Distribution reinvestment is not added unless already reflected in the source series.
Compare CVS and TSM against another ticker
Open a multi-ticker workspace without changing this focused pair page.
AIQ Factor Divergence
Where the two separate, on the four dimensions behind the AIQ Score. Bars read outward from a shared zero: further from the centre is a wider gap.
- Quality28 vs 96TSM +68
- Value70 vs 42CVS +28
- Momentum55 vs 74TSM +19
- Risk Resilience53 vs 68TSM +15
5 of 6 evidence groups favor TSM. TSM’s edge is concentrated in quality and momentum; CVS keeps a meaningful value edge.
What changed since the last close
Latest scored session 2026-09-10, compared against the prior scored session 2026-09-09.
Largest factor move: Momentum -1
No new signals fired.
Largest factor move: Momentum -8
No new signals fired.
TSM's lead narrowed by 2 AIQ points in the latest snapshot.
Deeper signal detail for each name lives on its own signals page — CVS and TSM both carry a full feed there.
The central trade-off
TSM (Taiwan Semiconductor Manufacturing Company Limited): the stronger current systematic profile, led by quality and momentum.
CVS (CVS Health Corp.): the counter-case, on value, valuation.
Which one fits your objective
The same two names rank differently depending on what you are optimizing for. All six reads are shown at once — none of them is hidden behind a toggle.
Balanced
TSMTSM on the overall AIQ Score, which weights Quality and Value most heavily.
Growth
TSMTSM on combined revenue and EPS growth.
Value
CVSCVS on the peer-relative Value factor, by 28 points.
Momentum
TSMTSM on the Momentum factor, by 19 points.
Lower downside
TSMTSM on Risk Resilience, by 15 points.
Analyst upside
TSMTSM on implied upside to the consensus price target.
AIQ vs Wall Street
Where the systematic read and the analyst consensus line up — and where they do not.
| Measure | CVS | TSM | Note |
|---|---|---|---|
| Implied upside to target | +15.9% | +32.2% | TSM has more room |
| Target dispersion | +31% | +38.4% | Lower is tighter analyst agreement |
| Consensus | Buy | Buy | Context, not a primary driver |
| Analysts covering | 14 | 7 | Higher coverage generally improves confidence |
Analyst targets are expectations, not predictions. Dispersion matters as much as the midpoint.
AIQ Agreement Matrix
5 of 6 covered evidence groups favor TSM. A wide gap backed by one group is a weaker case than a narrow gap backed by five.
| Evidence group | Favors | Reading |
|---|---|---|
| AIQ Score | TSM | 51 vs 70 |
| Fundamentals | TSM | revenue growth 5.6% vs 12%; TTM ROE 6.4% vs 39.3%; gross margin 14.2% vs 64.2%; operating margin 2% vs 56% |
| Valuation | CVS | Value 70 vs 42 |
| Technicals | TSM | Price vs 50-day -5.6% vs 3.4%; vs 200-day 9.7% vs 14.1% |
| Risk Resilience | TSM | Risk Resilience 53 vs 68 |
| Analyst expectations | TSM | Target upside 15.9% vs 32.2% |
✓ agrees with the overall verdict · ✕ points the other way. Groups marked “not covered” lack data on one or both of CVS and TSM and are excluded from the count.
AIQ Decision Stability
The conclusion rests on a wide gap and broad agreement. It is unlikely to turn on a single session.
- The AIQ gap is wide at 19 points. (supports the conclusion holding)
- 5 of 6 covered evidence groups point the same way. (supports the conclusion holding)
- The leader's signal state is cleanly positive. (supports the conclusion holding)
Stability combines the score gap, how broadly the evidence agrees, how steady the lead has been across daily snapshots, the current signal state on both names, and analyst dispersion on TSM.
How the comparison changed
119 daily snapshots · May 4 – Sep 10TSM lead: Stable — the AIQ differential has held near 19 points over 30 sessions.
- Today
- TSM +19
- 51 vs 70
- 7 sessions ago
- TSM +16
- 52 vs 68
- 30 sessions ago
- TSM +19
- 44 vs 63
- 90 sessions ago
- TSM +6
- 55 vs 61
The lead changed hands 3 times in this window, most recently on Jul 30 when TSM moved ahead of CVS.
AIQ Signal Divergence
Only the signals that bear on the head-to-head. A conflicted name is carrying bullish and bearish rules at the same time — the technical evidence is not pointing one way.
2 bullish / 0 bearish / 1 neutral
- Golden Cross Active — bullish, trend, long horizon (15.51%)
- Bollinger Band Squeeze — neutral, volatility, short horizon
- MACD Bullish Crossover — bullish, momentum, short horizon
4 bullish / 0 bearish
- Golden Cross Active — bullish, trend, long horizon (11.73%)
- EMA Ribbon Expansion Bullish — bullish, trend, medium horizon
- Uptrend Structure Active — bullish, trend, long horizon
Price vs model alignment
Whether the latest session's price move confirms what the model did over the same session, or contradicts it.
Neither the price nor the AIQ Score moved enough in the latest session to confirm or contradict the other (price -0.66%, AIQ 0 points).
Price is up while the AIQ Score moved down 2 points over the same session — price and model disagree (price +1.22%, AIQ -2 points).
What would flip this result
A state, not a forecast. These are the specific, observable changes that would reverse the verdict — not a price prediction.
- 1CVS closes the Quality gap — currently 68 points behind, the largest single contributor to TSM's edge.
- 2CVS's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend.
- 3TSM's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict.
- 4A regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
The full evidence
Every number behind the verdict. The leader is called above each group so you are not left to solve it from the table.
Fundamentals
TSM leads on balance| Metric | CVS | TSM |
|---|---|---|
| Revenue growth (YoY) | 5.6% | 12% |
| EPS growth (YoY) | 0.9% | 22.1% |
| Gross margin | 14.2% | 64.2% |
| Operating margin | 2% | 56% |
| Return on equity (TTM) | 6.4% | 39.3% |
| Debt to equity | 0.96 | 0.15 |
Performance
TSM leads 4 of 6 windows| Metric | CVS | TSM |
|---|---|---|
| 1 week (5 sessions) | -2% | 3% |
| 1 month (20 sessions) | 0.6% | -0.3% |
| 3 months (63 sessions) | -2.8% | 4.7% |
| 6 months (126 sessions) | 25.8% | 20.7% |
| Year to date | 20.1% | 40.9% |
| 1 year (252 sessions) | 35.6% | 73.2% |
Technicals
TSM has the stronger structure| Metric | CVS | TSM |
|---|---|---|
| RSI (14) | 56.4 | 57.7 |
| ADX (14) | 24.6 | 9.6 |
| Price vs 50-day | -5.6% | 3.4% |
| Price vs 200-day | 9.7% | 14.1% |
| Volatility (1M, annualized) | 24.2% | 27.3% |
Risk
TSM is the more resilient| Metric | CVS | TSM |
|---|---|---|
| Beta | 0.16 | 2.17 |
| Sharpe ratio | 0.96 | 1.43 |
| Sortino ratio | 1.17 | 2.31 |
| Max drawdown | -16.4% | -21.6% |
| Current drawdown | -13.8% | -10.4% |
| Annualized volatility | 30.8% | 40.4% |
| Value at risk (95%) | -2.5% | -4.1% |
Straight answers
Each answer is regenerated from the current snapshot, not written once and left to age.
Which is better, CVS or TSM?
On the Algovestiq AIQ Score, TSM is the stronger of the two as of Sep 11, 2026, scoring 70 against CVS's 51. The edge comes from quality and momentum. CVS is not without a case — it holds the better value profile, which matters more if that is the objective you are optimizing for. This is a systematic score, not a recommendation: it ranks the two on the same evidence, it does not know your holding period or tax position.
Is CVS or TSM the better buy right now?
TSM carries the stronger systematic profile as of Sep 11, 2026, and the comparison is rated Stable — 5 of 6 covered evidence groups agree. A Stable rating means the gap is wide and the evidence is broad, so the conclusion is unlikely to turn on a single session.
Why does the AIQ Score favor TSM over CVS?
The composite weights Quality, Value, Momentum and Risk Resilience. TSM leads Quality by 68 points; CVS leads Value by 28 points; TSM leads Momentum by 19 points. Where the two split, the factor with the larger weight carries the result.
Which has more analyst upside, CVS or TSM?
Analyst price targets imply +15.9% upside for CVS and +32.2% for TSM, so the Street currently favors TSM. The model and the Street agree here, which is a broader base of evidence than either alone. Analyst targets are expectations, not predictions, and dispersion matters as much as the midpoint.
Which is better value, CVS or TSM?
CVS is the better-valued of the two on the peer-relative Value factor. CVS on the peer-relative Value factor, by 28 points. The Value factor reads valuation relative to sector peers and to the company's own fundamental quality, so it is not the same as simply having the lower multiple.
Which has stronger growth, CVS or TSM?
TSM on combined revenue and EPS growth. Growth here is measured on reported revenue and earnings, not on forward estimates — it describes what the businesses have delivered, not what the Street expects next.
Which has stronger momentum, CVS or TSM?
TSM on the Momentum factor, by 19 points. Momentum is one of the four weighted factors in the AIQ composite. It has documented persistence over three- to twelve-month horizons, which makes it a timing input rather than a reason to hold something indefinitely.
Which is riskier, CVS or TSM?
TSM is the more resilient of the two, so the other name carries the higher downside risk. TSM on Risk Resilience, by 15 points. Risk Resilience is a weighted factor in the composite; position sizing usually responds to it more usefully than the buy/avoid decision does.
Is CVS more profitable than TSM?
TSM leads on the comparable margin measures — gross margin 14.2% vs 64.2%; operating margin 2% vs 56%; ttm roe 6.4% vs 39.3%.
Is TSM's lead over CVS getting stronger or weaker?
TSM lead: Stable — the AIQ differential has held near 19 points over 30 sessions. This is measured from 119 daily comparison snapshots between 2026-05-04 and 2026-09-10. The lead has changed hands 3 times in that window, most recently on 2026-07-30, when TSM moved ahead of CVS.
What would change the CVS vs TSM verdict?
The result is a state, not a forecast, so it changes when the underlying evidence changes. Concretely: CVS closes the Quality gap — currently 68 points behind, the largest single contributor to TSM's edge; CVS's Bollinger Band Squeeze turns directional — it is neutral today and would confirm a change in trend; TSM's Golden Cross Active breaks down — it is the strongest rule currently supporting the verdict; a regime shift changes factor weighting — Quality and Value carry the heaviest weights in the composite, so a rotation toward either would move the result most.
What do the current signals say about CVS and TSM?
CVS: 2 bullish / 0 bearish / 1 neutral. TSM: 4 bullish / 0 bearish. The most decision-relevant rule on CVS is Golden Cross Active (bullish, long horizon). On TSM it is Golden Cross Active (bullish, long horizon).
Compare CVS and TSM with others
Continue your research
This page answers which of the two. These answer the questions on either side of it.
How this comparison is scored
The Algovestiq AIQ Score composites four factors — Quality, Value, Momentum and Risk, each carrying a fixed weight. Sentiment is reported separately as SentimentPulse and is not folded into the composite. Scores refresh every trading day, and this page regenerates from the latest snapshot rather than being written once.
The verdict names a leader, states how broadly six independent evidence groups agree, and rates how durable that conclusion is given the score gap, its recent trajectory and the current signal state on both names.
How to use side-by-side comparison →This comparison is informational and educational, not investment advice. AIQ scores update daily; re-check after earnings, guidance or macro data that materially changes either name’s factor profile.